Evidence map›Paper›PMID 26037906›Full record

ArticleBMC pregnancy and childbirth2015

Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.

Olugbenga Oguntunde, Zulfiya Charyeva, Molly Cannon, William Sambisa, Nosakhare Orobaton, Ibrahim A Kabo, Kamil Shoretire, Saba'atu E Danladi, Nurudeen Lawal, Habib Sadauki

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Olugbenga OguntundeUSAID/TSHIP Abuja Nigeria, 3 Emir Sulaiman Adamu Street, GRA, Bauchi. ooguntunde@futuresgroup.com.
Zulfiya CharyevaFutures Group, Chapel Hill, USA. zcharyeva@futuresgroup.com.
Molly CannonFutures Group, Chapel Hill, USA. mcannon@futuresgroup.com.
William SambisaUSAID/TSHIP Abuja Nigeria, 3 Emir Sulaiman Adamu Street, GRA, Bauchi. william.sambisa@gmail.com.
Nosakhare OrobatonUSAID/TSHIP Abuja Nigeria, 3 Emir Sulaiman Adamu Street, GRA, Bauchi. norobaton@tshipnigeria.org.
Ibrahim A KaboUSAID/TSHIP Abuja Nigeria, 3 Emir Sulaiman Adamu Street, GRA, Bauchi. ikabo@tshipnigeria.org.
Kamil ShoretireUSAID/TSHIP Nigeria, Block 14 Shehu Kangiwa Secretariat, Sokoto, Nigeria. kshoretire@tshipnigeria.org.
Saba'atu E DanladiUSAID/TSHIP Abuja Nigeria, 3 Emir Sulaiman Adamu Street, GRA, Bauchi. sdanladi@tshipnigeria.org.
Nurudeen LawalUSAID/TSHIP Nigeria, Block 14 Shehu Kangiwa Secretariat, Sokoto, Nigeria. nlawal@tshipnigeria.org.
Habib SadaukiUSAID/TSHIP Abuja Nigeria, 3 Emir Sulaiman Adamu Street, GRA, Bauchi. hsadauki@tshipnigeria.org.
Achieving Health Nigeria Initiative · NGFutures Group (United States) · USBauchi State University · NGInstitut national de recherche en sciences et technologies du numérique · FRWilliams & Associates · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO4) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria.

methodsData were collected from 80 health facilities using a cross-sectional, mixed method (quantitative and qualitative) design. We assessed health facility readiness to manage PE/E and use MgSO4 as the drug of choice, through provider interviews, in-depth interviews with facility managers and an inventory of equipment and supply in facilities. Bivariate and qualitative data analyses were performed to isolate the principal enabling factors and barriers to the management of PE/E and use of MgSO4.

resultsThe majority of health facility providers correctly mentioned MgSO4 as the drug of choice for the prevention and termination of convulsions in severe PE/E (65 %). Sixty-four percent of the health facilities had service registers available. About 45 % of providers had been trained on the use of MgSO4 for the management of PE/E. Regarding providers' practices, 45 % of respondents indicated that MgSO4 was used to prevent and treat convulsions in severe PE/E in their facilities. Barriers to management of PE/E included inadequate numbers of skilled providers, frequent shortages of MgSO4, lack of essential equipment and supplies, irregular supply of electricity and water, and non-availability of guidelines and clinical protocols at the health facilities. Technical support to providers was inadequate.

conclusionThe study revealed that a constellation of factors adversely affect the management of PE/E and especially the use of MgSO4 by service providers. Efforts to improve the management of PE/E in facilities should include integrated programs that substantially improve provider and facility readiness to manage PE/E for better maternal and newborn health outcomes in Northern Nigeria.

Indexed as

Cross-Sectional StudiesEclampsiaEquipment and SuppliesFemaleHealth FacilitiesHealth WorkforceHumansMagnesium SulfateNigeriaPre-EclampsiaPregnancyQualitative ResearchTocolytic AgentsMagnesium SulfateTocolytic Agents

Identifiers

PMID26037906
PMCPMC4451740
OpenAlexW1500199755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.